Motasim Jawi

According to our database, Motasim Jawi authored at least 2 papers between 2024 and 2025.

Collaborative distances:

• Dijkstra number of six.
• Erdős number of five.

2025

Pyrazole-benzimidazole derivatives targeting MCF-7 breast cancer cells as potential anti-proliferative agents. 3D QSAR and In-silico investigations via molecular docking and molecular dynamics simulations.

Etibaria Belghalia, Farid Elbamtari, Motasim Jawi, Abdelkrim Guendouzi, Abdelouahid Sbai, M'barek Choukrad, Tahar Lakhlifi, Mohammed Bouachrine

Comput. Biol. Medicine, 2025

2024

Exploring a novel four-gene system as a diagnostic and prognostic biomarker for triple-negative breast cancer, using clinical variables.

Faisal Ali, Azhar Iqbal, Iqra Azhar, Adiba Qayyum, Syed Ali Hassan, Md. Sakib Al Hasan, Motasim Jawi, Hesham M. Hassan, Ahmed Al-Emam, Muhammad Sajid

Comput. Biol. Chem., 2024